Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2022
Seegene appoints Richard Creager to lead its U.S. subsidiary
Seegene announced the appointment of Richard S. Creager as CEO of its United States subsidiary, Seegene Technologies.
2021
Seegene reports third-quarter 2021 results
Seegene announced its third-quarter 2021 financial results, reporting sales revenue of KRW 305.3 billion and operating profit of KRW 128.6 billion.
2021
Seegene launches SARS-CoV-2 variant detection test
Seegene announced the launch of the Allplex SARS-CoV-2 Variants II Assay, a diagnostic test capable of screening six SARS-CoV-2 variants, including Delta and Delta Plus.
2021
Seegene and Bio-Rad sign U.S. diagnostic-products partnership
Seegene said it signed a partnership with Bio-Rad for clinical development and commercialization of infectious-disease molecular diagnostic products for the U.S. market, subject to clinical development and FDA approval.